OBJECT: There is little consensus regarding the indications for surgical CSF diversion (either with implanted temporizing devices [reservoir or subgaleal shunt] or shunt alone) in preterm infants with posthemorrhagic hydrocephalus. The authors determined clinical and neuroimaging factors associated with the use of surgical CSF diversion among neonates with intraventricular hemorrhage (IVH), and describe variations in practice patterns across 4 large pediatric centers. METHODS: The use of implanted temporizing devices and conversion to permanent shunts was examined in a consecutive sample of 110 neonates surgically treated for IVH related to prematurity from the 4 clinical centers of the Hydrocephalus Clinical Research Network (HCRN). Clinical, neuroimaging, and so-called processes of care factors were analyzed. RESULTS: Seventy-three (66%) of the patients underwent temporization procedures, including 50 ventricular reservoir and 23 subgaleal shunt placements. Center (p < 0.001), increasing ventricular size (p = 0.04), and bradycardia (p = 0.07) were associated with the use of an implanted temporizing device, whereas apnea, occipitofrontal circumference (OFC), and fontanel assessments were not. Implanted temporizing devices were converted to permanent shunts in 65 (89%) of the 73 neonates. Only a full fontanel (p < 0.001) and increased ventricular size (p = 0.002) were associated with conversion of the temporizing devices to permanent shunts, whereas center, OFCs, and clot characteristics were not. CONCLUSIONS: Considerable center variability exists in neurosurgical approaches to temporization of IVH in prematurity within the HCRN; however, variation between centers is not seen with permanent shunting. Increasing ventricular size-rather than classic clinical findings such as increasing OFCs-represents the threshold for either temporization or shunting of CSF.
OBJECT: There is little consensus regarding the indications for surgical CSF diversion (either with implanted temporizing devices [reservoir or subgaleal shunt] or shunt alone) in preterm infants with posthemorrhagic hydrocephalus. The authors determined clinical and neuroimaging factors associated with the use of surgical CSF diversion among neonates with intraventricular hemorrhage (IVH), and describe variations in practice patterns across 4 large pediatric centers. METHODS: The use of implanted temporizing devices and conversion to permanent shunts was examined in a consecutive sample of 110 neonates surgically treated for IVH related to prematurity from the 4 clinical centers of the Hydrocephalus Clinical Research Network (HCRN). Clinical, neuroimaging, and so-called processes of care factors were analyzed. RESULTS: Seventy-three (66%) of the patients underwent temporization procedures, including 50 ventricular reservoir and 23 subgaleal shunt placements. Center (p < 0.001), increasing ventricular size (p = 0.04), and bradycardia (p = 0.07) were associated with the use of an implanted temporizing device, whereas apnea, occipitofrontal circumference (OFC), and fontanel assessments were not. Implanted temporizing devices were converted to permanent shunts in 65 (89%) of the 73 neonates. Only a full fontanel (p < 0.001) and increased ventricular size (p = 0.002) were associated with conversion of the temporizing devices to permanent shunts, whereas center, OFCs, and clot characteristics were not. CONCLUSIONS: Considerable center variability exists in neurosurgical approaches to temporization of IVH in prematurity within the HCRN; however, variation between centers is not seen with permanent shunting. Increasing ventricular size-rather than classic clinical findings such as increasing OFCs-represents the threshold for either temporization or shunting of CSF.
Authors: S R Hintz; W K Poole; L L Wright; A A Fanaroff; D E Kendrick; A R Laptook; R Goldberg; S Duara; B J Stoll; W Oh Journal: Arch Dis Child Fetal Neonatal Ed Date: 2005-03 Impact factor: 5.747
Authors: Noel Tulipan; John C Wellons; Elizabeth A Thom; Nalin Gupta; Leslie N Sutton; Pamela K Burrows; Diana Farmer; William Walsh; Mark P Johnson; Larry Rand; Susan Tolivaisa; Mary E D'alton; N Scott Adzick Journal: J Neurosurg Pediatr Date: 2015-09-15 Impact factor: 2.375
Authors: Rowland H Han; Daniel Berger; Mohamed Gabir; Brandon S Baksh; Diego M Morales; Amit M Mathur; Christopher D Smyser; Jennifer M Strahle; David D Limbrick Journal: Childs Nerv Syst Date: 2017-09-07 Impact factor: 1.475
Authors: Rebecca A Dorner; Vera Joanna Burton; Marilee C Allen; Shenandoah Robinson; Bruno P Soares Journal: J Perinatol Date: 2018-08-30 Impact factor: 2.521
Authors: Tamara D Simon; Jeremiah Butler; Kathryn B Whitlock; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Nicole Mayer-Hamblett; Mandeep Tamber; John C Wellons; William E Whitehead; Jay Riva-Cambrin Journal: J Pediatr Date: 2014-03-21 Impact factor: 4.406
Authors: Diego M Morales; Christopher D Smyser; Rowland H Han; Jeanette K Kenley; Joshua S Shimony; Tara A Smyser; Jennifer M Strahle; Terrie E Inder; David D Limbrick Journal: Neurosurgery Date: 2021-02-16 Impact factor: 4.654
Authors: Beatriz Fernández-Muñoz; Cristina Rosell-Valle; Daniela Ferrari; Julia Alba-Amador; Miguel Ángel Montiel; Rafael Campos-Cuerva; Luis Lopez-Navas; María Muñoz-Escalona; María Martín-López; Daniela Celeste Profico; Manuel Francisco Blanco; Alessandra Giorgetti; Elena González-Muñoz; Javier Márquez-Rivas; Rosario Sanchez-Pernaute Journal: Stem Cells Transl Med Date: 2020-05-30 Impact factor: 6.940
Authors: Mohamed El-Dib; David D Limbrick; Terrie Inder; Andrew Whitelaw; Abhaya V Kulkarni; Benjamin Warf; Joseph J Volpe; Linda S de Vries Journal: J Pediatr Date: 2020-07-30 Impact factor: 4.406
Authors: Jenna E Koschnitzky; Richard F Keep; David D Limbrick; James P McAllister; Jill A Morris; Jennifer Strahle; Yun C Yung Journal: Fluids Barriers CNS Date: 2018-03-27